France Clinical Trials Support Service Market Analysis Report [2022-30] I Insights10

France Clinical Trials Support Service Market Analysis

$ 3999

This report presents a strategic analysis of the France Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the France Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.

ID: IN10FRCT002 CATEGORY: Clinical Trials GEOGRAPHY: France

Buy Now

France Clinical Trials Support Service Market Executive Summary

In 2020, France spent 209.2 billion euros on healthcare, or almost 3,100 euros per person. In 2019, health spending accounted for 11.1 percent of GDP, matching Germany as the largest share in the EU. In response to the COVID-19 issue, public health spending increased by 9.5 percent in 2020, while GDP fell by 8%. Every year, more than 1,000 clinics and private hospitals in France contribute to the care of nine million patients. These facilities do 55% of surgical procedures, two-thirds of day surgery, a quarter of mental hospitalizations, and 20% of births (FHP). In addition, there are 4,700 private non-profit organizations in France that treat 2.5 million people each year.

Clinical trials are a method of doing clinical research that is guided by a detailed protocol that has been carefully created to address a specific patient care question. Clinical trials can be broken down into five phases, each of which serves a particular function. Every trial follows a protocol that specifies the kinds of people who are allowed to take part in the study. In addition to stating the duration of the study, the studies also detail the precise plan of operations, tests, drugs, and doses inside the experiment. The rising expenses of drug development in recent years have forced pharma and biotech companies to explore for modernizations and more efficient ways of operating.

Clinical testing, assay design, and support services for clinical trials are all very helpful. It also includes duties like securing and storing research medications, securing clinical test sites, calculating drug dosages, and handling kits. Clinical test support services, which include clinical test site assistance, obtaining and storing study drugs, blinding of study drugs, patient recruitment, coordination, and reconciliation of returned medications, provide the preclinical foundation and research.

Significant changes were made to the clinical trial industry in 2021. Numerous clinical trials that had been postponed due to the pandemic were restarted with the development of COVID-19 vaccines. Approximately 44% more clinical trials started in the first quarter of 2021 compared to the same period in 2020. although it was once again possible to conduct clinical trials in person, a high rate of adoption of new technologies was still seen, with 74% of sponsors implementing remote monitoring and 77% of sites utilizing eRegulatory software.

Market Size and Key Findings

The France Clinical Trials Support Service Market size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.

France Clinical Trials Support Service Market Size (In USD Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

Three major factors are expected to drive the market in the upcoming years: the rising number of clinical trials, the high prevalence of chronic diseases, and the rise in the number of CROs providing services.

Competitive Landscape

Key Players

The prominent players operating in this market include Charles River Laboratories Inc.; Eurofins Scientific SE; IQVIA; Syneos Health Inc.; The Pharmaceutical Product Development LLC; Icon PLC; WuXi AppTec; LabCorp; Alcura; Parexel International

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Clinical Trials Support Service Market Segmentation

By Service Outlook (Revenue, USD Billion):

Clinical Trial Site Management
- Patient Recruitment Management
- Patient recruitment & registry services
- Patient retention
- Others
Data Management
Administrative Staff
IRB
Others

By Phase (Revenue, USD Billion):

Phase I
Phase II
Phase III
Phase IV

By Sponsor (Revenue, USD Billion):

Pharmaceutical & Biopharmaceutical
Medical Devices
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.